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ABSTRACT 
Epidemiological studies have shown an in-
verse correlation between diets rich in po-
lyphenols, flavonoids and reduced risk of 
cardiovascular disease. These associations 
were mainly ascribed to the antioxidant, 
antiaggregation and anticholesterol capa-
city of polyphenols. This association has 
been explained that atherogenesis is ini-
tiated by hypercholesterol, lipid peroxida-
tion and hyper aggregation platelet. The 
research was carried out to evaluate anti-
oxidant, anticholesterol and antiaggrega-
tion activities of methanol extract and frac-
tions of black tea (Camelia sinensis). To 
evaluate antioxidant activity of methanol 
extract and fractions were compared  with 
(-)-Epigallocatechine 3-gallate (EGCG), an-
ticholesterol activity were compared with 
simvastatin and antiaggregation activity 
were compared with aspirin. Antioxidant 
activity using the 1,1-diphenyl-2-picryl-hy-
drazyl (DPPH) free radical scavenging acti-
vity at two concentrations 100 µg/mL, 50 
µg/mL and anticholesterol was cholesterol 
oxidase activity at two concentrations 
0.005 µg/mL, 0.0025 µg/mL, the antiag-
gregation  activity  used epinephrine (EPN)  
 
 
agonist at two concentrations 300 μM, 75 
μM and one concentration 37.1 µg/mL of 
methanol extract and fractions of black 
tea. To know the difference of treatment, 
the data were analysed using Analysis of 
Variance (ANOVA) and be continued Dun-
can’s new multiple range test. The results 
showed that DPPH scavenging activity 
were high (88.59-93.556%), the anticho-
lesterol showed high activity (93.663-
97.434%) and the antiaggregation sho-
wed low up to high activity (79.967-
4.31%). Using Duncan’s new multiple ra-
nge test showed that anti-oxidant activity 
were not different among extract and 
fractions of black tea, the highest anti-
cholesterol activity was black tea extract 
0.005 µg/mL (97.434%) and the highest 
antiaggregation activity was ethyl acetate 
fraction on 75 μM EPN agonist (4.310 %), 
water fraction 37.1 µg/mL with 300 μM 
EPN agonist (21.833%). 
Key words : Black tea, Camelia sinensis, an-
tioxidant, anticholesterol, anti-
aggregation, flavonoids, cardio-
vascular disease 
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ABSTRAK 
Potensi Antioksidan, 
Antikolesterol dan Antiagregasi 
Platelet Teh Hitam (Camelia 
sinensis ) 
Berdasar studi epidemiologi menunjukkan 
adanya hubungan terbalik yaitu antara 
makanan yang kaya polifenol, flavonoid 
dan pengurangan risiko penyakit kardio-
vaskuler. Hubungan ini terutama disebab-
kan oleh aktivitas antioksidan, antikoleste-
rol dan antiagregasi dari polifenol, serta 
aterogenesis yang dipicu oleh hiperkoles-
terol, peroksidasi lipid dan hiper agregasi 
platelet. Penelitian ini dilakukan untuk me-
ngetahui aktivitas antioksidan, antiagregasi 
dan antikolesterol dari ekstrak metanol 
dan fraksi-fraksi teh hitam (Camelia sinen-
sis). Untuk mengetahui aktivitas antioksi-
dan ekstrak metanol dan fraksi-fraksi teh 
hitam dibanding (-)-Epigallocatechine 3-
gallate (EGCG), aktivitas antikolesterol di-
bandingkan simvastatin dan antiagregasi 
dibandingkan aspirin. Aktivitas antioksidan 
adalah penghambatan radikal bebas 1,1-
diphenyl-2-picryl-hydrazyl (DPPH) dilaku-
kan pada 2 konsentrasi yaitu 100 µg/mL, 
50 µg/mL dan antikolesterol adalah aktivi-
tas kolesterol oksidase dilakukan pada 2 
konsentrasi yaitu 100 µg/mL, 50 µg/mL. 
Aktivitas antiagregasi menggunakan ago-
nist epinephrine (EPN) pada konsentrasi 
agonist 300 μM, 75 μM dan konsentrasi 
37,1 µg/mL ekstrak metanol dan fraksi-
fraksi teh hitam. Untuk mengetahui perbe-
daan perlakuan, data dianalisis mengguna-
kan Analysis of Variance (ANOVA) dilanjut-
kan uji jarak berganda Duncan. Hasil pe-
nelitian menunjukkan pemerangkapan DP-
PH memiliki aktivitas antioksidan tinggi 
sebesar 88,59-93,556%, antikolesterol me-
nunjukkan aktivitas kolesterol oksidase 
tinggi sebesar 93,663-97,434%, antiagre-
gasi menunjukkan aktivitas rendah sampai 
tinggi sebesar 79,967-4,31%. Berdasarkan 
hasil uji jarak berganda Duncan aktivitas 
antioksidan tidak berbeda nyata antar eks-
trak dan fraksi-fraksi teh hitam, aktivitas 
antikolesterol tertinggi adalah ekstrak teh 
hitam 0,005 µg/mL sebesar 97,434% ak-
tivitas antiagregasi tertinggi pada agonist 
EPN 75 μM sebesar 4,310% dan fraksi air 
37,1 µg/mL pada agonist EPN 300 μM se-
besar 21,833%. 
Kata kunci : Teh hitam, Camelia sinensis, an-
tioksidan antikolesterol, anti-
agregasi, flavonoid, penyakit 
kardiovaskuler 
INTRODUCTION 
High plasma cholesterol is one 
of the greatest risk factors that con-
tribute to the prevalence and severity 
of cardiovascular disease (CVD) (Sasa-
zuki et al. 2000; Yung et al. 2008). 
Variety of factors contribute to the be-
neficial effects of functional foods, 
much attention has been addressed to 
plant polyphenols (Grassi et al. 2008). 
Epidemiological studies have shown 
an inverse correlation between diets 
rich in polyphenols and reduced risk 
of CVD (Hertog et al. 1996; Mukamal 
et al. 2002; Yung et al. 2008). Tea 
(Camelia sinensis L) is one of the 
most popular beverages in the world 
because of its attractive flavor and 
aroma. Polyphenols are the most sig-
nificant group of tea components, es-
pecially flavonoids (Willson 1999; 
Cabrera et al. 2006). 
Studies using animal models of 
atherosclerosis indicate that dietary 
flavonoid consumption delays atheros-
clerotic plaque development (Grassi et 
al. 2008). In a long-term study of a 
Dutch cohort the highest tea consum-
ption was associated with a lower risk 
of death from coronary heart disease 
(Geleijnse et al. 2002; Yang and Lan-
dau 2000). Black tea is a major sour-
ce of flavonoids, with antioxidant ef-
fects that may help to retard atheros-
clerosis (Sesso et al. 1999). The po-
tential protective effect of flavonoids 
Bul. Littro. Vol. 22  No. 1, 2011, 74 - 83 
 76 
has been attributed to antioxidant, an-
tithrombogenic and antiinflammatory  
properties (Hertog 1996; Middleton 
1998; Leenen et al. 2005; Geleijnse et 
al. 2002). Flavonoids may also improve 
vascular function in animal experi-
ments (Duffy et al. 2001; Geleijnse et 
al. 2002). The relative risk of incident 
myocardial infarction was lower in tea 
drinkers with a daily intake >375 mL  
than in non tea drinkers. An increased 
intake of tea and flavonoids may con-
tribute to the primary prevention of is-
chemic heart disease (Geleijnse et al. 
2002). Fresh tea leaves are rich in fla-
vanol monomers known as catechins. 
The principal catechins found in tea 
are (-)-epicatechin (EC), (-)-epigallo-
catechin (EGC), (-)-epicatechin gallate 
(ECG) and (-)-epigallocatechin gallate 
(EGCG). EGCG is the most abundant 
catechin in tea (Graham 1992; Frei and 
Higdon 2003). In manufacturing black 
tea, the tea leaves are crushed to al-
low the polyphenol oxidase to catalyse 
the oxidation, leading to polymeriza-
tion of catechins. The remaining cate-
chins account for 3-10% of the solids 
in brewed black tea. Theaflavins (TF), 
which include theaflavin (TF1), thea-
flavin-3-gallate (TF2), theaflavin-3'-gal-
late (TF2B) and theaflavin-3,3'-digalla-
te (TF3), are key to the characteristic 
color and taste of black tea, and ac-
count for 2-6% of the solids in brewed 
black tea. The major fractions of black 
tea polyphenols, accounting for >20% 
of the solids in brewed black tea, are 
known as thearubigens (Yang and 
Landau 2000). 
This research was to evaluate 
the antioxidant, anticholesterol and an-
tiaggregation platelet of methanol ex-
tract, fractions of black tea by in vitro 
assay. 
MATERIALS AND METHODS 
Plant and chemical material 
Dried black tea leaves obtai-
ned from Walini Tea Company, Indo-
nesia. DPPH (1,1-diphenyl-2-picrylhy-
drazyl) (Sigma Chemical Co.); HPLC 
grade methanol (Merck); (-) epigallo-
catechin gallate (EGCG) (Sigma Che-
mical Co.); dimethyl sulfoxide 
(Merck); Cholesterol KIT (Randox) re-
agent contains 4-Aminoantipyrine, 
phenol, peroxidase, cholesterol este-
rase, cholesterol oxidase; Simvastatin 
(Kimia Farma); Cholesterol (Sigma 
Chemical Co.), Epinephrine (EPN) 
(Helena Laboratories 2008). 
Extraction and fractionation 
The dried black tea leaves we-
re extracted by maceration technique, 
produced 7.8% methanol extract The 
fractionation used liquid partition me-
thod. The first step used n-hexane: 
water (7:3) as solvent produced hexa-
ne fraction 20.45%. The second step 
used ethyl acetate : water (9:1 produ-
ced ethyl acetate fraction 10.93% and 
the third step used n-butanol : water 
(9:1) as solvent produced butanol 
fraction 3.30% and the remain was 
water fraction 14.14%. 
DPPH radical scavenging activity 
assay 
The DPPH assay was carried 
out as described by Frum and Viljoen 
(2006). Pipette 50 µL of sample (two 
concentrations) enter at the microtitre 
plate and then were added 200 µL of 
0.077 mmol/L methanol solution of 
DPPH and the reaction mixture was 
shaken vigorously and kept in the 
dark for 30 min at room temperature, 
DPPH was determined by microplate 
reader  at 517 nm. 
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Anticholesterol activity assay 
The anticholesterol assay was 
carried out as described by Iswantini 
et al. (2005) and Cholesterol (Chol) 
Enzymatic Endpoint Method (Randox 
Laboratories Ltd. 2009). Cholesterol 
was disolved in chloroform until achi-
eving 25 mg/10 mL. Anticholesterol as-
say used Cholesterol manual (Randox 
2009). Pipette 5 µL of sample (two 
concentrations) enter at the microtitre 
plate and then were added 1000 µL 
Randox reagent and 5 µL cholesterol 
as sample. Blank solution comprised of 
10 L distilled water and 1000 L Ran-
dox reagent; negative control compri-
sed of 10 µL cholesterol and 1000 L 
Randox reagent; standard comprised 
of 10 µL Randox standard and 1000 L 
Randox reagent. Mixed and incubated 
for 10 minutes at room temperature, 
measured the absorbance by micropla-
te reader at 500 nm against reagent 
blank. 
Platelet antiaggregation activity 
assay 
Aggregation activity was mea-
sured by Platelet Aggregation Chromo-
genic Kinetic System (PACKS-4). Pippe-
te 450 μL of platelet poor plasma 
(PPP) into a cuvette. Pippete 450 μL 
platelet rich plasma (PRP) and 40 μL 
sample into cuvettes with stir bar, in-
cubate the cuvettes at 370 C for 3-5 
minutes. Insert the PPP cuvette into 
appropriate channel and set the instru-
ment, insert the PRP cuvette into the 
appropriate channel. Add 50 μL of EPN 
at level 300 μM, 75 μM to the PRP cu-
vette and record the percent aggrega-
tion (Helena Laboratories 2008). 
 
 
Statistic analysis 
To verify the statistical signifi-
cance of the parameter, the data we-
re calculated including the values of 
means and standard deviation (M ± 
SD) and 95% confidence interval (CI) 
of means. To compare among treat-
ments, used analysis of variance 
(ANOVA) with completely randomized 
designs. P-values of less than 0.05 
were considered as statiscally signifi-
cant. Furthermore, to know the diffe-
rence of levels among treatments and 
to know the best treatmet used Dun-
can’s new multiple range test 95% 
confidence interval. Statistical analysis 
used SPSS 16.0 program. 
RESULTS AND DISCCUSSIONS 
The DPPH scavenging activity 
There were no different 
among concentrations and among an-
tioxidant agents. All treatment (ex-
tract, fractions of black tea and two 
concentrations) had similiar and high 
antioxidant activity (p = 0.07 > 0.05), 
the highest antioxidant activity was 
butanol fraction at level 100 μg/mL 
(93.56%), the lowest antioxidant was 
ethyl acetate fraction at level 100 μg/ 
mL (88.59%). 
The DPPH assay base on the 
scavenging of DPPH radicals is follo-
wed by monitoring the decrease in 
absorbance at 517 nm which occurs 
due to reduction by the antioxidant 
(AH) or reaction with  free radical 
species (R*) : 
DPPH* + AH (antioxidant)  DPP-H + A* (free radical) 
Base on DPPH scavenging acti-
vity test,  sample contains antioxidant 
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Which hydrogen (H) captured by DPPH 
free radical or antioxidant donates hy-
drogen (H) was indicated purple color 
(DPPH free radical) become 1,1- 
diphenyl-2-picrylhydrazyn yellow color 
(Kikugawa et al. 2001; Gordon 2001). 
When DPPH* reacts with an antioxi-
dant compound, which can donate hy-
drogen, it is reduced. The changes in 
colour (from deep-violet to light-
yellow) were measured at 517 nm 
(Miliauskas et al. 2003). 
Black tea had high antioxidant 
activity due to it contains flavonoids, 
there are EC, ECG, EGC, EGCG, TF1, 
TF3, TF2B, Thearubigins, Kaempferol, 
Myricetin,  Quercetin (USDA 2003). 
The most widely recognized properties 
of tea polyphenols are their antioxidant 
activities, arising from their ability to 
scavenge reactive oxygen species 
(Yang and Landau 2000). Dietary an-
tioxidants, especially tea and tea fla-
vonoids have attracted increasing inte-
rest due to their relatively potent radi-
cal scavenging (Nanjo et al. 1996;  
Mandel et al. 2004). 
The anticholesterol activity 
Anticholesterol activity among 
extract, fractions of black tea and con-
centrations treatmet were siginicant 
(p=0.00<0.05) (Table 1.) 
All of anticholesterol candidate 
agents from black tea including me-
thanol extract and four fractions sho-
wed high anticholesterol activity 
>93.66% although were lower than 
simvastatin. All of anticholesterol 
agents except butanol fraction showed 
that high concentration (0.005 μg/mL) 
were more active than lower concen-
tration. 
 
 
 
Previous study some catechins 
have been shown to inhibit a key 
enzyme (squalene epoxidase) in the 
pathway of cholesterol biosynthesis. 
Theaflavin was found to be twice as 
effective in blocking the activity of 
squalene epoxidase (Leung et al. 
2001; Wang et al. 2001; Cooper et al. 
2005). Black tea extract contains po-
lyphenols, flavonoids, catechins 
(USDA 2003), by in vitro and in vivo 
studies that tea or catechins inhibit 
the intestinal absorption of dietary 
lipids. Studies in vitro indicate that 
catechins, particularly EGCG, interfere 
with the emulsification, digestion, and 
micellar solubilization of lipids, critical 
steps involved in the intestinal ab-
sorption of dietary fat, cholesterol, 
and other lipids. Tea or its catechins 
lower the absorption and tissue accu-
mulation of other lipophilic organic 
compounds so can be used as safe 
and effective lipid-lowering therapeu-
tic agents (Koo and Noh 2007). In 
animals, catechins reduce the solubi-
lity of cholesterol in micelles an action 
consistent with the observation that 
high doses of tea modulate choleste-
rol levels in animals fed high choles-
terol (Yang et al. 2001; Cooper et al. 
2005). 
Base on the Table 1 showed 
that simvastatin had high anticho-
lesterol activity, this data was valida-
ted with previous study that statins as 
3-hydroxy-3-methylglutaryl coenzyme 
A (HMG-CoA) reductase inhibitors 
(i.e., simvastatin) have been accepted 
as the first choice for lowering low-
density lipoprotein (LDL), cholesterol 
levels (Hubacek and Bobkova  2006). 
These inhibitors act primarily by inhi-
biting the cellular biosynthesis of cho-
lesterol in the liver (Risovic et al. 
2006). 
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According the antioxidant acti-
vity showed that methanol extract and  
fractions  of  black  tea  had high anti-
oxidant activity and according to Table 
1 showed that extract and fractions of 
black tea indicated high anticholesterol 
activity.  This results were validated 
with previous research that the posi-
tive effects of natural antioxidant nut-
rients on cardiovascular dysfunction, 
resulting from multiple factors, such as 
atherosclerotic plaques, low-density 
lipoprotein (LDL) oxidation, triglyceri-
des, and cholesterol metabolism (Man-
del et al. 2004). 
The platelet antiaggregation acti-
vity 
Antiaggregation activity among 
black tea extract, fractions and agonist 
concentrations treatmet were sigini-
cant (p=0.00<0.05) (Table 2). All of 
antiaggregation agents, except hexane 
fraction were capable to lower aggre-
gation compared with negative control 
(without antiaggregation agent) both 
in two concentrations of EPN agonist. 
The ethyl acetate fraction was 
more active than aspirin at the 75 μM 
EPN agonist, water fraction, methanol 
fraction had same antiaggregation  ac- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
tivity as aspirin at the 75 μM EPN 
agonist. Methanol extract, ethyl ace-
tate, butanol, water fraction of black 
tea and aspirin had same antiag-
gregation activity at the 300 μM EPN 
agonist. The methanol extract, ethyl 
acetate, butanol and water fraction of 
black tea except hexane fraction sho-
wed promising anti-aggregation acti-
vity. 
This research result was vali-
dated with previous research that ba-
se on in vitro studies have shown that 
isolated flavonoids at high physiologi-
cal concentrations can reduce platelet 
aggregation and markers of platelet 
activation (Rein et al. 2000; Hodgson 
2008). Several in vitro studies show 
that flavonoids component inhibit pla-
telet aggregation, a major process 
contributing to both the development 
of athersclerosis and acute platelet 
thrombus formation followed by em-
bolism-producing cyclic flow reduction 
in stenosed arteries. Flavonoid antiag-
gregation effects may be attributed to 
inhibition of thromboxane formation, 
thromboxane receptor antagonism, 
blunting hydrogen peroxide produc-
tion, or inhibition of phospholipase C 
(Tzeng et al. 1991; Pignatelli et al. 
2000; Buck et al. 2003).  Flavonoids  
inhibit  platelet  aggregation  because 
 
 
 
Table 1. Means, standard deviation and Duncan’s new multiple range test of 
extract and fractions of black tea on anticholesterol activity (%) 
Concen-
trations 
(μg/mL) 
Samples 
Methanol extract Hexane 
fraction 
Ethyl ace-tate 
fraction 
Butanol fraction Water fraction Simvastatin 
0.005 97.43±0.15 d 95.85±0.29 c 96.88±0.31 d 95.40±0.14 bc 96.88±0.17 d  99.35±0.51 e 
0.0025 95.40±0.34  bc 95.29±0.27 b  95.81±0.24 bc 95.45±0.20 bc 93.66±0.22 a 95.40±0.25 bc 
Note : The data showed mean and standard deviation. The same small letters  (among 
extract, fractions and simvastatin at two level concentrations) show no significant 
at the 5 % (Duncan’s Post Hoc  test) 
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of their antioxidant activity, either by 
inhibiting the formation of endogenous 
mediators derived from phospholipid 
peroxidation, by blocking enzymatic 
free radical production, or by reducing 
platelet sensitivity to agonists by pre-
venting lipid peroxidation (Murphy et 
al. 2003). Previous research that flavo-
noids (quercetin and catechin) had 
antioxidant activity significantly inhibit 
the release of platelet H2O2, whose 
production is associated with collagen-
induce platelet aggregation. Quercetin 
and catechin reduced phosphati-dylse-
rine (PS) exposure, thrombin forma-
tion, phosphatidylinositol 4,5-biphosp-
hate (PIP2) level and resynthesis after 
platelet activation with collagen, 
thrombin or calcium ionophore. Flavo-
noids also prevented [Ca+2], increase 
induced by collagen inducer (Buck et 
al. 2003). Quercetin and catechin are 
flavonoids antioxidant, synergistically 
inhibited platelet function (in vitro as-
say) by blunting the release of hydro-
gen peroxide (H2O2) from platelets,
 
subsequently reducing phospholipase 
C activation, calcium mobilization, and 
inositol  phosphate  synthesis.   Aspirin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
as antiplatelet agent on all levels con-
centration inducer  by inhibiting the 
production of TXA2, inhibiting the en-
zyme COX (Hyun-Jung et al. 2006). 
These results suggest that the 
antiplatelet activity of methanol ex-
tract, ethyl acetate, butanol and wa-
ter fractions of black tea may be me-
diated by TXA2 receptor blockade with 
TXA2 synthase inhibition and suppres-
sion of cytosolic [Ca2+] mobilization, 
inhibited the activation of phospholi-
pase C, followed by inhibition of pro-
tein kinase C activity and TXA2 forma-
tion, thereby leading to inhibition of 
the phosphorylation of P47 and intra-
cellular Ca2+  mobilization, finally re-
sulting in inhibition of platelet aggre-
gation (McKenzie 2004; Sheu et al. 
2004). TXA2 formation cause the bond 
between platelets is weak and platelet 
aggregation is reversible (primer ag-
gregation), secondary aggregation ne-
ed longer time and produces irrever-
sible aggregation platelet (McKenzie 
2004). Epinephrine  in the presence of 
fibrinogen and Ca2+ (in vitro) induces 
both primary and secondary aggre-
gation, potentiates aggregation 
(Kjeldsen et al. 1995). 
 
 
 
Table 2. Means, standard deviation and Duncan’s new multiple range test of 
extract and fractions of black tea on antiaggregation activity (%) 
Concen-
trations 
(μM) of 
EPN 
Samples 
Negative 
control 
Methanol 
extract 
Hexane 
fraction 
Ethyl acetate 
fraction 
Butanol 
fraction 
Water fraction Aspirin 
300 45.83±4.31 e 23.47±3.31 bc 76.50±3.15 f 28.33±3.70 bcd  25.90±2.80 bc  21.83±2.35 b 22.97±3.01 bc 
75 88.27±3.31 g 34.40±3.05 d  79.97±6.35 f 4.31±1.81  a 40.73±3.26 e 26.90±2.49 bc  29.10±4.40 cd 
Note : The data showed mean and standard deviation. The same small letters (among extract, 
fractions, negative control and aspirin on two level concentrations of agonist) show no 
significant at the 5 % (Duncan’s Post Hoc test) 
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CONCLUSIONS 
Methanol extract, fractions of 
black tea had high antioxidant activity, 
were potential to inhibit lipid peroxi-
dation, high anticholesterol activity we-
re potential to lower cholesterol level, 
antiplatelet activity were potential to 
inhibit aggregation platelet in hype-
raggregation individu. 
Black tea was promising beve-
rage to inhibit and reduce cardiovas-
cular disease risk. 
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